Published in Nucleic Acids Res on June 01, 2003
The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res (2004) 3.30
Molecular architecture of quartet MOZ/MORF histone acetyltransferase complexes. Mol Cell Biol (2008) 1.89
MOZ is essential for maintenance of hematopoietic stem cells. Genes Dev (2006) 1.56
Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. Haematologica (2010) 1.25
The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors. Blood (2009) 1.13
The hematopoietic transcription factor AML1 (RUNX1) is negatively regulated by the cell cycle protein cyclin D3. Mol Cell Biol (2005) 1.08
The MYSTerious MOZ, a histone acetyltransferase with a key role in haematopoiesis. Immunology (2013) 1.04
Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein. Mol Cell Biol (2005) 1.03
The MOZ histone acetyltransferase in epigenetic signaling and disease. J Cell Physiol (2014) 0.95
Histone acetyltransferase MOZ acts as a co-activator of Nrf2-MafK and induces tumour marker gene expression during hepatocarcinogenesis. Biochem J (2007) 0.89
MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2. Mol Cancer (2007) 0.77
SARS coronavirus 3b accessory protein modulates transcriptional activity of RUNX1b. PLoS One (2012) 0.76
Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer. Oncogene (2016) 0.75
Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell (1997) 18.91
Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell (1997) 13.53
AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell (1996) 9.74
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47
The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet (1996) 4.59
Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature (1990) 3.29
Macrophage inflammatory protein-1. Cytokine Growth Factor Rev (2002) 2.93
Groucho proteins: transcriptional corepressors for specific subsets of DNA-binding transcription factors in vertebrates and invertebrates. Genes Dev (1998) 2.92
The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol Cell Biol (1995) 2.70
CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol (1996) 2.42
PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials. Mol Cell Biol (1994) 2.27
Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J (1998) 2.09
Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J Cell Sci (2000) 2.08
Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1 alpha, and MIP-1 beta, members of the chemokine superfamily of proinflammatory cytokines. J Immunol (1993) 1.99
PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol (1994) 1.91
A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J Biol Chem (2000) 1.84
Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol Cell Biol (1994) 1.77
The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Nat Med (2002) 1.75
Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. EMBO J (2001) 1.62
Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Gene (2000) 1.52
Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. Blood (1995) 1.48
Role of Cbfa1 in osteoblast differentiation and function. Semin Cell Dev Biol (2000) 1.29
Structures of human genes coding for cytokine LD78 and their expression. Mol Cell Biol (1990) 1.27
AML1A and AML1B can transactivate the human IL-3 promoter. J Immunol (1997) 1.27
Characterization of the Elk-1 ETS DNA-binding domain. J Biol Chem (1995) 1.24
Mechanisms of transcriptional regulation by Runt domain proteins. Semin Cell Dev Biol (2000) 1.24
Functional dissection of the alpha and beta subunits of transcription factor PEBP2 and the redox susceptibility of its DNA binding activity. J Biol Chem (1996) 1.23
Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2. Blood (1998) 1.15
Runt and Lozenge function in Drosophila development. Semin Cell Dev Biol (2000) 1.14
Alterations of the AML1 transcription factor in human leukemia. Semin Cell Dev Biol (2000) 1.12
Function of CBFbeta/Bro proteins. Semin Cell Dev Biol (2000) 1.04
Genomic structure of murine macrophage inflammatory protein-1 alpha and conservation of potential regulatory sequences with a human homolog, LD78. J Immunol (1991) 1.03
Regulation of GM-CSF gene transcription by core-binding factor. Cell Growth Differ (1996) 0.99
Potential roles for RUNX1 and its orthologs in determining hematopoietic cell fate. Semin Cell Dev Biol (2000) 0.96
A new translocation that rearranges the AML1 gene in a patient with T-cell acute lymphoblastic leukemia. Cancer Genet Cytogenet (2002) 0.95
Inducible expression of nuclear factor IL-6 increases endogenous gene expression of macrophage inflammatory protein-1 alpha, osteopontin and CD14 in a monocytic leukemia cell line. Int Immunol (1998) 0.94
Characterization of cytokine LD78 gene promoters: positive and negative transcriptional factors bind to a negative regulatory element common to LD78, interleukin-3, and granulocyte-macrophage colony-stimulating factor gene promoters. Mol Cell Biol (1993) 0.91
Cooperation between core binding factor and adjacent promoter elements contributes to the tissue-specific expression of interleukin-3. J Biol Chem (1996) 0.89
Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1. Nucleic Acids Res (2002) 0.88
Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch. Nat Genet (2006) 2.68
Therapeutic hypothermia preserves antioxidant defenses after severe traumatic brain injury in infants and children. Crit Care Med (2009) 1.70
Missense mutations that cause Van der Woude syndrome and popliteal pterygium syndrome affect the DNA-binding and transcriptional activation functions of IRF6. Hum Mol Genet (2008) 1.50
The osteoblast transcription factor Runx2 is expressed in mammary epithelial cells and mediates osteopontin expression. J Biol Chem (2003) 1.39
Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin. Breast Cancer Res (2011) 1.05
Oct-1 counteracts autoinhibition of Runx2 DNA binding to form a novel Runx2/Oct-1 complex on the promoter of the mammary gland-specific gene beta-casein. Mol Cell Biol (2005) 1.03
Repression of transcription by WT1-BASP1 requires the myristoylation of BASP1 and the PIP2-dependent recruitment of histone deacetylase. Cell Rep (2012) 1.02
Cytoskeletal protein filamin A is a nucleolar protein that suppresses ribosomal RNA gene transcription. Proc Natl Acad Sci U S A (2012) 0.99
The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells. Mol Cancer (2010) 0.95
Inhibition of Notch1 signaling by Runx2 during osteoblast differentiation. J Bone Miner Res (2011) 0.85
Albuterol multidose dry powder inhaler efficacy and safety versus placebo in children with asthma. Allergy Asthma Proc (2017) 0.81
Pharmacokinetics and pharmacodynamics of albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane in children with asthma. Allergy Asthma Proc (2016) 0.78
A brief response to "Religious and secular death": a parting of the ways. Bioethics (2013) 0.75
Ultra-precision engineering: from physics to manufacturing. Philos Trans A Math Phys Eng Sci (2012) 0.75
Albuterol multidose dry powder inhaler and albuterol hydrofluoroalkane versus placebo in children with persistent asthma. Allergy Asthma Proc (2016) 0.75
Quality improvement curricula in pediatric residency education: obstacles and opportunities. Acad Pediatr (2011) 0.75
Preface. Philos Trans A Math Phys Eng Sci (2012) 0.75